Pacer Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.98M Buy
+1,134,512
New +$4.65M 0.01% 680
2025
Q2
Sell
-1,789,098
Closed -$2.63M 3506
2025
Q1
$2.63M Sell
1,789,098
-9,941,673
-85% -$23.7M 0.01% 864
2024
Q4
$52M Buy
11,730,771
+450,949
+4% +$1.83M 0.11% 196
2024
Q3
$46.5M Buy
11,279,822
+2,372,183
+27% +$12.8M 0.1% 218
2024
Q2
$58.1M Buy
8,907,639
+1,701,452
+24% +$12M 0.13% 186
2024
Q1
$62.8M Buy
+7,206,187
New +$87.4M 0.14% 171
2023
Q3
Sell
-2,466,228
Closed -$26.2M 2639
2023
Q2
$26.2M Buy
2,466,228
+204,428
+9% +$2.2M 0.11% 199
2023
Q1
$23.8M Buy
2,261,800
+711,756
+46% +$7.97M 0.1% 203
2022
Q4
$19.2M Buy
1,550,044
+278,591
+22% +$3.16M 0.1% 175
2022
Q3
$13.2M Buy
1,271,453
+338,287
+36% +$3.84M 0.09% 169
2022
Q2
$10.8M Buy
+933,166
New +$11M 0.08% 211
2021
Q2
Sell
-6,889
Closed -$77K 1478
2021
Q1
$77K Sell
6,889
-2,506
-27% -$26.5K ﹤0.01% 1332
2020
Q4
$107K Sell
9,395
-332
-3% -$3.63K ﹤0.01% 1358
2020
Q3
$87K Buy
+9,727
New +$96.7K ﹤0.01% 1270
2018
Q4
Sell
-11,471
Closed -$177K 791
2018
Q3
$177K Buy
+11,471
New +$181K 0.01% 1042
2018
Q1
Sell
-3,501
Closed -$44K 1086
2017
Q4
$44K Buy
+3,501
New +$45.7K ﹤0.01% 1029

Other funds holding IRWD

Pacer Advisors's IRWD Position: Q1 2026 in Review

Pacer Advisors opened a new position in Ironwood Pharmaceuticals (IRWD) in Q1 2026: 1,134,512 shares worth $3.98M. The stake represents 0.01% of the portfolio and ranks #680 among its holdings. This is a return to the name: Pacer Advisors previously reported a position in IRWD as recently as Q1 2025.

Pacer Advisors first reported a position in IRWD in Q4 2017 and has held it in 16 quarters since. The position peaked at $62.8M in Q1 2024. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Pacer Advisors held 1,134,512 shares of Ironwood Pharmaceuticals worth $3.98M as of Q1 2026.
  • Ironwood Pharmaceuticals was a new Pacer Advisors position in Q1 2026.
  • Ironwood Pharmaceuticals made up 0.01% of Pacer Advisors's portfolio in Q1 2026, its #680 holding.
  • Pacer Advisors first reported a position in Ironwood Pharmaceuticals in Q4 2017 and has held it in 16 quarters since.
  • Pacer Advisors's Ironwood Pharmaceuticals position peaked at $62.8M in Q1 2024.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Pacer Advisors's 13F filing for Q1 2026, filed 6 May 2026.